Superpower links FDA approval of apitegromab to muscle loss risk on GLP-1 drugs
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Recap by typeshit. Post by Superpower on X.